Open AccessThe resolution of the Expert Council on Interstitial Lung Diseases in Systemic Scleroderma (Moscow, October 14, 2019)
Author(s) -
С. Н. Авдеев,
Л. П. Ананьева,
Е. В. Жиляев,
Е. В. Зонова,
А. А. Клименко,
O. Koneva,
А. М. Лила,
Е. С. Першина,
A.A. Stremoukhov Stremoukhov,
С. А. Терпигорев,
И. Е. Тюрин,
Н. А. Шостак
Publication year - 2020
Publication title -
sovremennaâ revmatologiâ
Language(s) - English
Resource type - Journals
eISSN - 2310-158X
pISSN - 1996-7012
DOI - 10.14412/1996-7012-2020-1-125-128
Subject(s) - scleroderma (fungus) , medicine , nintedanib , systemic scleroderma , dermatology , lung , interstitial lung disease , systemic therapy , intensive care medicine , pathology , idiopathic pulmonary fibrosis , inoculation , dermatomyositis , cancer , breast cancer
The conclusion of the Expert Council presents the results of discussing the diagnosis and therapy of interstitial lung diseases in systemic scleroderma. The reason for this discussion was the emergence of new data on the use of nintedanib in this category of patients.